- Home
- / BMP Pharma Trading
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BMP Pharma Trading financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€4.6
2024-10-29
Revenue
€2 K
FY, 2024
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 7.0K | 1.0K | 1.0K | 4.0K | 2.0K | 2.0K | |
| Cost of goods sold | 3.0K | 1.0K | 1.0K | 4.0K | 2.0K | 1.0K | |
| Gross profit | 58.0K | 78.0K | 52.0K | 50.0K | 193.0K | 45.0K | 80.0K |
| Gross profit margin, % | 828.6% | 7800.0% | 5200.0% | 1250.0% | 9650.0% | 4000.0% | |
| Operating expense total | 741.0K | 763.0K | 745.0K | 845.0K | 1.4M | 1.9M | 2.0M |
| Depreciation and amortization | 1.0K | 1.0K | 1.0K | 2.0K | |||
| EBITDA | (683.0K) | (685.0K) | (693.0K) | (795.0K) | (1.2M) | (1.8M) | (1.9M) |
| EBITDA margin, % | -9757.1% | -68500.0% | -69300.0% | -19875.0% | -58950.0% | -95300.0% | |
| EBIT | 510.0K | 303.0K | 296.0K | 3.2M | 2.2M | 4.1M | 4.2M |
| EBIT margin, % | 7285.7% | 30300.0% | 29600.0% | 80625.0% | 111250.0% | 209050.0% | |
| Interest income | 17.0K | 21.0K | 5.0K | 8.0K | 15.0K | 18.0K | |
| Interest expense | 2.0K | 13.0K | 11.0K | 8.0K | 5.0K | ||
| Pre tax profit | 545.0K | 341.0K | 298.0K | 3.2M | 2.2M | 4.1M | 4.2M |
| Income tax expense | 85.0K | 32.0K | 128.0K | 593.0K | 652.0K | 1.3M | 1.3M |
| Net Income | 460.0K | 309.0K | 170.0K | 2.6M | 1.6M | 2.8M | 2.9M |